Cargando…
Randomized Polypill Crossover Trial in People Aged 50 and Over
BACKGROUND: A Polypill is proposed for the primary prevention of cardiovascular disease in people judged to be at risk on account of their age alone. Its efficacy in reducing cholesterol and blood pressure is uncertain. METHODS: We conducted a randomized double-blind placebo-controlled crossover tri...
Autores principales: | Wald, David S., Morris, Joan K., Wald, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399742/ https://www.ncbi.nlm.nih.gov/pubmed/22815989 http://dx.doi.org/10.1371/journal.pone.0041297 |
Ejemplares similares
-
Starting the polypill: the use of a single age cut-off in males and females
por: Wald, Nicholas J, et al.
Publicado: (2016) -
Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016) -
Randomized Crossover Trial of Phosphate-binding Medication on Serum Phosphate Levels in Patients With Aortic Stenosis
por: Wald, David S., et al.
Publicado: (2019) -
Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up
por: Morris, Joan K., et al.
Publicado: (2015) -
Reconciling the Evidence on Serum Homocysteine and Ischaemic Heart Disease: A Meta-Analysis
por: Wald, David S., et al.
Publicado: (2011)